December 13, 2024

Researchers Target 2035 for Psoriasis Cure

A recent paper in the Journal of Investigative Dermatology discusses the potential of a cure for psoriasis through early therapeutic intervention and a personalized medicine approach.

Conexiant

December 13, 2024

Large Study Reveals Melanoma's Hidden Risks

Analysis of over 280,000 melanoma patients reveals these survivors face significantly elevated risks of developing 12 different types of second primary cancers, with the risk being particularly pronounced in younger patients and those with thicker tumors.

Conexiant

December 12, 2024

Key Genetic Variants in Palmoplantar Keratoderma

In a Danish cohort of 142 patients with palmoplantar keratoderma, researchers identified DSP variants linked to cardiomyopathy risk in seemingly typical cases, highlighting why genetic testing matters beyond just diagnosis.

Conexiant

December 09, 2024

Reduced Infection Rates with Long-Term Dupilumab in Kids

A recent study reveals that dupilumab can reduce infection rates in young children with moderate-to-severe atopic dermatitis, offering potential long-term benefits for this patient population.

Conexiant

December 09, 2024

AI, AR & Social Media Transform Cosmetic Dermatology

Learn how AI and AR technologies are reshaping cosmetic dermatology and the impact of social media platforms on beauty standards.

Conexiant

November 26, 2024

Moisturizers in Dermatitis: Risk vs Reward

A recent review finds that moisturizers, commonly used in dermatitis care, may lead to adverse effects in children with eczema, emphasizing the need for moderation and personalized recommendations for their use. Published in the Journal of the American Academy of Dermatology.

Conexiant

November 21, 2024

Deuruxolitinib Shows Promise for Alopecia

Deuruxolitinib achieved significant hair regrowth in a Phase 3 clinical trial. 

Conexiant

November 20, 2024

Analysis Identifies New Genetic Loci for Atopic Dermatitis

A recent analysis in the Journal of Investigative Dermatology identified 77 genetic loci associated with atopic dermatitis, including 10 novel variants, in a genome-wide study of about 1.1 million participants.

Conexiant

November 20, 2024

Topical Ruxolitinib Offers Rapid Relief for Atopic Dermatitis

Recent studies show that Ruxolitinib cream provided significant relief from skin pain and improved sleep quality and quality of life for adolescents and adults with mild-to-moderate atopic dermatitis.

Conexiant